SR 95531 hydrobromide (Gabazine)

(HB0901)
Technical documents: SDS CoA Datasheet

Product overview

Name SR 95531 hydrobromide (Gabazine)
Alternative names Gabazine | GBZ
Purity >98%
Customer comments

We regularly use Hello Bio Gabazine (SR 95531) in the lab.We especially like the formulation where you only need to add 1ml of water to make a 10mM stock solution. Verified customer, The University of Newcastle

I am satisfied with the quality, quick delivery and follow-up of your product. Verified customer, Shimane University

We used our first aliquot of SR95531 (Gabazine) last week. The experiment was a critical one for us and the SR95531 worked exactly as expected – 100% block of a GABAergic IPSP (inhibitory postsynaptic potential). Verified customer, University of Michigan

Good compound. This compound is routinely used in our lab to isolate AMPA and NMDA currents. So we are using it a lot every day. There are no complaints about it! Verified customer, Karolinska Institutet

Description Selective, competitive GABAA receptor antagonist
Write Your Own Review
You're reviewing:SR 95531 hydrobromide (Gabazine)
Rate this item:

Images

Figure 1. Gabazine inhibition of evoked and spontaneous GABAA-R mediated IPSCs in mouse cortical neurons

Gabazine is commonly used to reduce levels of inhibition by antagonising GABAA receptors. It is commonly used at concentrations between 10 - 200 µM. Gabazine from Hello Bio blocks spontaneous inhibitory post synaptic currents (IPSC) and evoked IPSCs. It was effective at 1 µM and completely blocked GABAA receptors at 20 µM. For assay protocol, see #Protocol 1 in Application Notes below
SR 95531 hydrobromide (Gabazine) product vial image | Hello Bio

Biological Data

Biological description

SR 95531 hydrobromide (Gabazine) is a selective and competitive GABAA receptor antagonist (Ki = 150 nM for displacement of [3H]-GABA from rat membranes).


SR 95531 (Gabazine) displaces GABA from the GABAAR agonist binding site to prevent receptor activation. It also acts as a negative allosteric inhibitor of channel opening to inhibit GABAA receptor activation by anaesthetic agents. It also displays low affinity glycine receptor inhibition.


SR 95531 (Gabazine) inhibits GABA-induced Cl- currents to reduce GABA-mediated synaptic inhibition.


SR 95531 additionally shows convulsive actions.

Application notes

Gabazine (SR 95531) is commonly used to reduce levels of inhibition by antagonising GABAA receptors. It is commonly used at concentrations between 10 – 200 μM.

Gabazine (SR 95531) from Hello Bio blocks spontaneous inhibitory post synaptic currents (IPSC) and evoked IPSCs (see Fig 1 above). It was effective at 1 μM and completely blocked GABAA receptors at 20 μM.

 

#Protocol 1: Evoked and spontaneous inhibitory post synaptic currents (IPSCs)

  • Whole cell voltage clamp recordings were obtained from layer V neurons of the mouse prelimbic cortex brain slice.
  • A stimulating electrode was placed in layers II/III and IPSCs were evoked by a single square (150 μs) pulse every 10 sec at a stimulus intensity that gave a reliable IPSC.
  • IPSCs were evoked at a range of neuron holding voltages to measure the reversal potential of the current to ensure it was GABAergic.
  • Neurons were held at 0mV and IPSCs continuously stimulated and recorded in response to 5 min applications of varying concentrations of Gabazine until complete receptor inhibition.
  • Spontaneous IPSCs were recorded before and after addition of Gabazine by holding the neuron at 0mV and recording for 10 sec.
  • All recordings for IPSCs were made in the presence of AMPAR antagonists.

Solubility & Handling

Storage instructions Room temperature
Solubility overview Soluble in water (25mM) and in DMSO (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >98%
Chemical name 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide
Molecular Weight 368.23
Chemical structure SR 95531 hydrobromide (Gabazine)  [104104-50-9] Chemical Structure
Molecular Formula C15H17N3O3.HBr
CAS Number 104104-50-9
PubChem identifier 107895
SMILES COC1=CC=C(C=C1)C2=NN(C(=N)C=C2)CCCC(=O)O.Br
Source Synthetic
InChi InChI=1S/C15H17N3O3.BrH/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20;/h4-9,16H,2-3,10H2,1H3,(H,19,20);1H
InChiKey GFZHNFOGCMEYTA-UHFFFAOYSA-N
MDL number MFCD00055135
Appearance White solid

References for SR 95531 hydrobromide (Gabazine)

References are publications that support the biological activity of the product
  • Sequential steps underlying neuronal plasticity induced by a transient exposure to gabazine.

    Pegoraro S et al (2010) J Cell Physiol 222(3) : 713-28.
  • The kinetics of inhibition of rat recombinant heteromeric alpha1beta glycine receptors by the low-affinity antagonist SR-95531.

    Beato M et al (2007) J Physiol 580(Pt 1) : 171-9.
  • Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA.

    Yeung et al (2003) Mol Pharmacol 36(1) : 2-8.
  • The differential antagonism by bicuculline and SR95531 of pentobarbitone-induced currents in cultured hippocampal neurons.

    Uchida I et al (1996) Eur J Pharmacol 307(1) : 89-96.
  • Biochemical characterization of the interaction of three pyridazinyl-GABA derivatives with the GABAA receptor site.

    Heaulme M et al (1986) Brain Res 384(2) : 224-31.

5 Item(s)

Publications
These publications cite the use of SR 95531 hydrobromide (Gabazine) purchased from Hello Bio:
  • PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits

    Yi F et al (2020) Neuropharmacology 25 : 107971
    PubMedID: 31987864
  • Negative allosteric modulation of GluN1/GluN3 NMDA receptors

    Zhu Z et al (2020) Neuropharmacology 176 : 108117
    PubMedID: 32389749
  • Mechanisms Underlying Long-Term Synaptic Zinc Plasticity at Mouse Dorsal Cochlear Nucleus Glutamatergic Synapses

    Vogler NW et al (2020) J Neurosci 40(26) : 4981-4996
    PubMedID: 32434779
  • NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism

    Sitzia G et al (2020) Neuropharmacology 174 : 108136
    PubMedID: 32474027
  • Synapse-specific Opioid Modulation of Thalamo-cortico-striatal Circuits

    Birdsong et al (2019) bioRxiv : https://doi.org/10.1101/525782

Items 36 to 40 of 59 total

Page